Skip to content

Study on the Influence of High-Risk HPV Infection-Associated Cervical Diseases on Cervical Metabolomics

Study on the Influence of High-Risk HPV Infection-Associated Cervical Diseases on Cervical Metabolomics

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108951
Enrollment
Unknown
Registered
2025-09-09
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV-Related Cervical Diseases

Interventions

Normal:Not Applicable
HPV Infection:Not Applicable
CIN I:Not Applicable
CIN II:Not Applicable
Cancer:Not Applicable
CIN III:None

Sponsors

Guangzhou Women and Children’s Medical Center Liuzhou Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Females aged 18 and above, who are not postmenopausal. 2. Patients infected with high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) undergo biopsy under colposcopy with a fully visible transformation zone. 3. Diagnosis of chronic cervicitis, CIN I, CIN II, CIN III, or cervical cancer is made based on biopsy pathology results. 4. No use of vaginal douches, antibiotics, or antifungal medications within 30 days prior to treatment. 5. No cervical physical therapy has been performed within the 3 months prior to treatment.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breastfeeding. 2. History of cervical excision, cervical neoplasia, or pelvic radiotherapy. 3. Concurrent acute inflammation of the reproductive system. 4. Concurrent severe impairment of heart, liver, or kidney function. 5. Concurrent diabetes or immune system diseases. 6. Coagulation function abnormalities.

Design outcomes

Primary

MeasureTime frame
Metabolomics test;

Secondary

MeasureTime frame
Bioinformatics Analysis (Metabolic Pathway Analysis);Upstream Gene Validation in Metabolic Pathways;

Countries

China

Contacts

Public ContactJing Chen

No. 50, Boyuan Avenue, Yufeng District, Liuzhou City, Guangxi and No. 50, Yingshan Street, Chengzhong District, Liuzhou City, Guangxi

chenjing20152721@163.com+86 150 7825 8742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026